Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk of failing both methotrexate and mycophenolate mofetil from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trial.
Reddy AK, Miller DC, Sura AA, Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, Murugan B, Vedhanayaki R, Lim LL, Suhler EB, Doan T, Al-Dhibi HA, Goldstein DA, Arellanes-Garcia L, Acharya NR. Reddy AK, et al. J Ophthalmic Inflamm Infect. 2023 Jun 9;13(1):29. doi: 10.1186/s12348-023-00350-5. J Ophthalmic Inflamm Infect. 2023. PMID: 37294447 Free PMC article.
Intraocular Inflammation Associated with IRAK4 Deficiency.
Gonzales JA, Nortey J, Reddy A, Doan T, Acharya NR. Gonzales JA, et al. Ocul Immunol Inflamm. 2023 May;31(4):874-876. doi: 10.1080/09273948.2022.2059523. Epub 2022 Apr 20. Ocul Immunol Inflamm. 2023. PMID: 35442872 Free article. No abstract available.
Reduced Dose Methotrexate and Mycophenolate Mofetil in Noninfectious Uveitis: A Sub-Analysis from the First-Line Antimetabolites as Steroid Sparing Therapy (FAST) Trial.
Sura AA, Sun Y, Reddy AK, Rathinam SR, Gonzales JA, Thundikandy R, Vedhanayaki R, Kanakath A, Murugan B, Doan TA, Lim LL, Suhler EB, Al-Dhibi HA, Acharya NR; FAST Research Group. Sura AA, et al. Among authors: reddy ak. Ocul Immunol Inflamm. 2024 Aug;32(6):955-960. doi: 10.1080/09273948.2023.2165949. Epub 2023 Jan 26. Ocul Immunol Inflamm. 2024. PMID: 36701644 Free article. Clinical Trial.
Association Between Baseline Macular Morphologic Features on Optical Coherence Tomography and Visual Outcomes in Patients with Vogt-Koyanagi-Harada Disease.
Sundararajan M, Rathinam SR, Thundikandy R, Kanakath A, Balamurugan S, Vedhanayaki R, Miller DC, Lim LL, Suhler EB, Al-Dhibi HA, Arellanes-Garcia L, Reddy AK, Feng S, Doan T, Porco TC, Shantha JG, Acharya NR, Gonzales JA. Sundararajan M, et al. Among authors: reddy ak. Ocul Immunol Inflamm. 2025 Feb;33(2):263-270. doi: 10.1080/09273948.2024.2391420. Epub 2024 Aug 27. Ocul Immunol Inflamm. 2025. PMID: 39190826 Free article. Clinical Trial.
Treatment of Ocular Surface Disease in Ocular Cicatricial Pemphigoid.
Abbott KS, Palestine AG, Hauswirth SG, Gregory DG, Patnaik JL, Reddy AK. Abbott KS, et al. Among authors: reddy ak. Ocul Immunol Inflamm. 2024 Dec;32(10):2479-2485. doi: 10.1080/09273948.2024.2413892. Epub 2024 Oct 9. Ocul Immunol Inflamm. 2024. PMID: 39383489 Free article.
282 results